PRECIGEN, INC. (PGEN) Corporate Subsidiaries
PRECIGEN, INC. (PGEN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PGEN
CIK: 1356090
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: VA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBeth Prophet-Reese
Audit LocationBaltimore, Maryland, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-24 | 2026-09-23 | FORM 4 | 0000950103-26-014457 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | FORM 4 | 0000950103-26-013201 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001958244-26-000558 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0000950103-26-012875 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-23 | FORM 4 | 0000950103-26-012874 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-23 | FORM 4 | 0000950103-26-012873 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0000950103-26-012872 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-23 | FORM 4 | 0000950103-26-012871 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-23 | FORM 4 | 0000950103-26-012870 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001959173-26-006433 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001959173-26-006432 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001959173-26-006346 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0000950103-26-012078 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001104659-26-092515 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001959173-26-005704 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001356090-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | FORM 8-K | 0000950103-26-011876 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | FORM 4 | 0000950103-26-011711 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001959173-26-005546 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-31 | FORM 4 | 0000950103-26-011578 | View SEC Doc Filr Page |
| 144 | 2026-07-31 | — | 144 Filing | 0001959173-26-005476 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | FORM 4 | 0000950103-26-009980 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | FORM 4 | 0000950103-26-009979 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | FORM 4 | 0000950103-26-009978 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001959173-26-005006 | View SEC Doc Filr Page |